Thomas Weisel Downgrades Luminex (LMNX) to Market Weight
More News related to LMNX
- Luminex Corporation to Present at JPMorgan Healthcare Conference
- Luminex Corporation and Mingyuan Medicare Development Company Sign Distribution Agreement
- Luminex Corporation Announces First Commercial Shipment of FLEXMAP 3D Systems
- Unusual 11 Mid-Day Movers 11/07: LFG, FSYS, AN, KNOT Higher; GNW, DPTR, EGOV, SRZ Lower
- Luminex Corp (LMNX) Tops Q3 View By 7c
More News related to Downgrades
- ARGUS Downgrades Smith International (SII) to Hold
- Cantor Fitzgerald Downgrades Audiocodes (AUDC) to Hold After Negative 4Q Preannouncement
- MDB Capital Downgrades Ener1 (HEV) to Sell, Suspends Earnings Model and Valuation on Stock No Longer Justified
- DA Davidson Downgrades Ambassadors Group (EPAX) to Neutral
- SunTrust Downgrades Ruby Tuesday, Inc. (RT) to Neutral
Thomas Weisel downgrades Luminex (Nasdaq: LMNX) from Overweight to Market Weight with a $26 price target.
Luminex Corporation develops, manufactures, and sells proprietary biological testing technologies and products for applications in the life sciences industry.
Related Categories
DowngradesStocks Mentioned
-1.46Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
